Susan Longar, MD
Ophthalmology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 1 carrier
- Office
- 1
- Since medical school
- 35 years
- University of California, Davis School of Medicine, 1991
Offices
1 location · Farallon Eye Physicians Corp · 4 clinicians in this group
Looking this up.
Hospitals listed: Ahmc Seton Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Longar’s office at (650) 992-9223 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$286,131
Medicare paid this office $286,131 for 1,017 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 546 | $54,942 | $100 |
| Removal of cataract with insertion of prosthetic lens | 57 | $53,248 | $522 |
| Return visit (30+ min) | 319 | $37,187 | $116 |
| Photography of the retina | 939 | $36,295 | $34 |
| Imaging of retina | 450 | $17,755 | $37 |
See all 17 services
| Established patient complete exam of visual system | 546 | $54,942 | $100 |
| Removal of cataract with insertion of prosthetic lens | 57 | $53,248 | $522 |
| Return visit (30+ min) | 319 | $37,187 | $116 |
| Photography of the retina | 939 | $36,295 | $34 |
| Imaging of retina | 450 | $17,755 | $37 |
| Exam of visual field with extended testing | 223 | $14,468 | $64 |
| New patient visit (45+ min) | 94 | $12,458 | $133 |
| Established patient problem focused exam of visual system | 131 | $10,835 | $70 |
| Removal of recurring cataract in lens capsule using a laser | 24 | $10,565 | $302 |
| Imaging of optic nerve | 248 | $9,334 | $32 |
| Ultrasound scan to determine eye length and lens power | 77 | $5,308 | $35 |
| Short return visit (20+ min) | 55 | $4,972 | $86 |
| Long return visit (40+ min) | 19 | $3,244 | $171 |
| Short return visit | 38 | $2,157 | $54 |
| New patient visit (60+ min) | 12 | $2,096 | $175 |
| Ultrasound scan of cornea to determine thickness | 200 | $2,046 | $10 |
| Measurement of corneal curvature and depth of eye | 16 | $752 | $47 |
Procedures Medicare counted
| Cataract surgery | 247 | More than 87% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 126 | 121 | 133 | 136 | 86 | 102 |
| Removal of recurring cataract in lens capsule using a laser | 67 | 42 | 54 | 27 | 28 | 35 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,017 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 15% · Women 63% · Also on Medicaid 13% · Health risk score 0.97. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 39% · Coronary heart disease 21% · Chronic kidney disease 21% · Atrial fibrillation 14% · Cancer 13% · Heart failure 11% · Depression 10% · COPD 8% · Stroke 5% · Dementia 4%.
The office billed $828,484, Medicare allowed $395,529 and paid $286,131; for 4,045 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,017 | 4,045 | 76 | 0.97 | $828,484 | $286,131 |
| 2023 | 1,016 | 4,076 | 76 | 1.00 | $870,202 | $269,897 |
| 2022 | 883 | 3,585 | 76 | 1.03 | $789,908 | $255,584 |
| 2021 | 939 | 3,784 | 75 | 1.02 | $827,798 | $289,997 |
| 2020 | 760 | 2,896 | 76 | 1.04 | $671,935 | $221,814 |
| 2019 | 943 | 3,551 | 76 | 1.09 | $779,853 | $296,904 |
| 2018 | 914 | 3,603 | 75 | 1.09 | $880,407 | $327,636 |
| 2017 | 936 | 3,286 | 75 | 1.12 | $916,876 | $297,261 |
| 2016 | 1,029 | 3,810 | 75 | 1.13 | $937,462 | $323,597 |
| 2015 | 1,059 | 3,742 | 75 | 1.10 | $802,426 | $291,722 |
| 2014 | 948 | 3,390 | 75 | 1.07 | $699,209 | $246,382 |
| 2013 | 967 | 3,205 | 75 | 1.08 | $705,151 | $255,495 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Established patient complete exam of visual system | 823 | $89,718 | $105 |
| Removal of cataract with insertion of prosthetic lens | 51 | $44,725 | $520 |
| Photography of the retina | 870 | $32,767 | $34 |
| Established patient problem focused exam of visual system | 212 | $20,544 | $82 |
| Imaging of retina | 428 | $17,015 | $37 |
| Exam of visual field with extended testing | 239 | $15,366 | $62 |
| New patient visit (45+ min) | 107 | $14,422 | $135 |
| Imaging of optic nerve | 253 | $9,052 | $32 |
| Removal of recurring cataract in lens capsule using a laser | 20 | $8,583 | $307 |
| Ultrasound scan to determine eye length and lens power | 80 | $6,173 | $34 |
| Ultrasound scan of cornea to determine thickness | 202 | $2,073 | $10 |
2022: 11 services
| Established patient complete exam of visual system | 678 | $70,032 | $100 |
| Removal of cataract with insertion of prosthetic lens | 77 | $67,905 | $499 |
| Photography of the retina | 730 | $26,844 | $33 |
| Established patient problem focused exam of visual system | 241 | $20,195 | $70 |
| Imaging of retina | 376 | $15,046 | $36 |
| Exam of visual field with extended testing | 206 | $12,420 | $59 |
| New patient visit (45+ min) | 85 | $10,728 | $126 |
| Removal of recurring cataract in lens capsule using a laser | 20 | $7,996 | $296 |
| Imaging of optic nerve | 206 | $7,229 | $31 |
| Ultrasound scan to determine eye length and lens power | 83 | $5,952 | $33 |
| Ultrasound scan of cornea to determine thickness | 177 | $1,820 | $10 |
2021: 12 services
| Established patient complete exam of visual system | 724 | $81,695 | $107 |
| Removal of cataract with insertion of prosthetic lens | 72 | $69,216 | $520 |
| Photography of the retina | 744 | $30,289 | $36 |
| Established patient problem focused exam of visual system | 249 | $22,827 | $75 |
| Removal of recurring cataract in lens capsule using a laser | 41 | $16,380 | $303 |
| New patient visit (45+ min) | 109 | $14,106 | $129 |
| Imaging of retina | 326 | $13,982 | $39 |
| Exam of visual field with extended testing | 212 | $13,731 | $62 |
| Imaging of optic nerve | 219 | $8,045 | $33 |
| Ultrasound scan to determine eye length and lens power | 91 | $6,563 | $34 |
| Ultrasound scan of cornea to determine thickness | 157 | $1,661 | $10 |
| Imaging of front third of eye | 23 | $709 | $31 |
2020: 11 services
| Established patient complete exam of visual system | 588 | $60,759 | $97 |
| Removal of cataract with insertion of prosthetic lens | 66 | $59,210 | $489 |
| Photography of the retina | 600 | $26,410 | $39 |
| Established patient problem focused exam of visual system | 193 | $16,078 | $72 |
| Removal of recurring cataract in lens capsule using a laser | 31 | $11,892 | $283 |
| Exam of visual field with extended testing | 175 | $10,310 | $58 |
| Imaging of retina | 241 | $9,246 | $36 |
| New patient visit (45+ min) | 72 | $8,726 | $121 |
| Imaging of optic nerve | 191 | $5,975 | $29 |
| Ultrasound scan to determine eye length and lens power | 70 | $4,539 | $32 |
| Ultrasound scan of cornea to determine thickness | 117 | $1,185 | $10 |
2019: 11 services
| Established patient complete exam of visual system | 750 | $84,581 | $103 |
| Removal of cataract with insertion of prosthetic lens | 72 | $78,221 | $621 |
| Photography of the retina | 674 | $35,515 | $47 |
| Established patient problem focused exam of visual system | 237 | $20,987 | $71 |
| Removal of recurring cataract in lens capsule using a laser | 43 | $19,700 | $294 |
| Exam of visual field with extended testing | 228 | $14,907 | $63 |
| New patient visit (45+ min) | 104 | $13,208 | $127 |
| Imaging of retina | 199 | $8,421 | $38 |
| Imaging of optic nerve | 198 | $6,904 | $33 |
| Ultrasound scan to determine eye length and lens power | 83 | $5,503 | $31 |
| Ultrasound scan of cornea to determine thickness | 189 | $2,131 | $11 |
2018: 11 services
| Removal of cataract with insertion of prosthetic lens | 105 | $108,575 | $593 |
| Established patient complete exam of visual system | 774 | $89,786 | $103 |
| Photography of the retina | 562 | $33,415 | $54 |
| Established patient problem focused exam of visual system | 248 | $23,367 | $73 |
| Exam of visual field with extended testing | 236 | $15,001 | $62 |
| Removal of recurring cataract in lens capsule using a laser | 33 | $11,897 | $305 |
| Imaging of retina | 291 | $11,754 | $37 |
| New patient visit (45+ min) | 70 | $8,744 | $125 |
| Ultrasound scan to determine eye length and lens power | 107 | $7,529 | $35 |
| Imaging of optic nerve | 196 | $6,517 | $32 |
| Ultrasound scan of cornea to determine thickness | 196 | $2,697 | $13 |
2017: 11 services
| Removal of cataract with insertion of prosthetic lens | 97 | $105,452 | $596 |
| Established patient complete exam of visual system | 741 | $76,692 | $96 |
| Established patient problem focused exam of visual system | 298 | $28,349 | $70 |
| Exam of visual field with extended testing | 269 | $17,468 | $62 |
| Imaging of retina | 412 | $17,457 | $36 |
| Removal of recurring cataract in lens capsule using a laser | 24 | $9,625 | $292 |
| Ultrasound scan to determine eye length and lens power | 100 | $8,260 | $40 |
| Imaging of optic nerve | 247 | $8,092 | $31 |
| New patient visit (45+ min) | 69 | $7,339 | $106 |
| Photography of the retina | 80 | $5,021 | $63 |
| Ultrasound scan of cornea to determine thickness | 236 | $3,303 | $13 |
2016: 14 services
| Removal of cataract with insertion of prosthetic lens | 113 | $124,863 | $609 |
| Established patient complete exam of visual system | 364 | $41,184 | $113 |
| Return visit (30+ min) | 428 | $30,502 | $70 |
| Imaging of retina | 468 | $23,097 | $41 |
| Exam of visual field with extended testing | 276 | $17,498 | $61 |
| Established patient problem focused exam of visual system | 157 | $13,746 | $82 |
| Ultrasound scan to determine eye length and lens power | 115 | $12,576 | $36 |
| Removal of recurring cataract in lens capsule using a laser | 29 | $11,284 | $297 |
| Imaging of optic nerve | 267 | $10,695 | $38 |
| Short return visit (20+ min) | 184 | $10,497 | $52 |
| New patient visit (45+ min) | 57 | $6,837 | $120 |
| Short return visit | 136 | $5,352 | $34 |
| Ultrasound scan of cornea to determine thickness | 198 | $2,740 | $13 |
| New patient visit (30+ min) | 11 | $1,016 | $92 |
2015: 15 services
| Removal of cataract with insertion of prosthetic lens | 85 | $88,485 | $602 |
| Return visit (30+ min) | 780 | $69,487 | $85 |
| Imaging of retina | 469 | $24,015 | $42 |
| Short return visit (20+ min) | 316 | $23,353 | $59 |
| Exam of visual field with extended testing | 288 | $18,372 | $63 |
| Imaging of optic nerve | 272 | $10,871 | $40 |
| New patient visit (45+ min) | 80 | $10,635 | $133 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $10,211 | $300 |
| Ultrasound scan to determine eye length and lens power | 78 | $8,785 | $36 |
| Short return visit | 139 | $6,784 | $35 |
| Ultrasound scan of cornea to determine thickness | 192 | $2,626 | $14 |
| New patient visit (60+ min) | 13 | $2,182 | $168 |
| New patient visit (30+ min) | 21 | $1,655 | $79 |
| Long return visit (40+ min) | 12 | $1,505 | $125 |
| Removal of eyelashes using forceps | 12 | $743 | $44 |
2014: 14 services
| Removal of cataract with insertion of prosthetic lens | 68 | $72,527 | $604 |
| Return visit (30+ min) | 696 | $61,136 | $83 |
| Imaging of retina | 414 | $21,143 | $41 |
| Short return visit (20+ min) | 297 | $19,990 | $56 |
| Exam of visual field with extended testing | 260 | $16,525 | $61 |
| Imaging of optic nerve | 247 | $9,772 | $39 |
| New patient visit (45+ min) | 66 | $8,386 | $127 |
| Ultrasound scan to determine eye length and lens power | 71 | $7,425 | $35 |
| Short return visit | 131 | $6,244 | $37 |
| Removal of recurring cataract in lens capsule using a laser | 19 | $6,075 | $289 |
| Long return visit (40+ min) | 31 | $3,020 | $97 |
| Ultrasound scan of cornea to determine thickness | 209 | $2,803 | $13 |
| New patient visit (60+ min) | 14 | $2,365 | $169 |
| New patient visit (30+ min) | 13 | $1,033 | $79 |
2013: 13 services
| Removal of cataract with insertion of prosthetic lens | 77 | $78,735 | $601 |
| Return visit (30+ min) | 751 | $60,497 | $80 |
| Short return visit (20+ min) | 363 | $25,943 | $58 |
| Imaging of retina | 343 | $17,379 | $42 |
| Exam of visual field with extended testing | 260 | $16,732 | $63 |
| Imaging of optic nerve | 257 | $10,337 | $40 |
| Removal of recurring cataract in lens capsule using a laser | 22 | $7,435 | $297 |
| Ultrasound scan to determine eye length and lens power | 66 | $7,333 | $41 |
| New patient visit (45+ min) | 53 | $6,105 | $115 |
| Short return visit | 132 | $5,877 | $34 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $5,658 | $314 |
| Ultrasound scan of cornea to determine thickness | 252 | $3,323 | $13 |
| New patient visit (30+ min) | 13 | $1,185 | $91 |
Medicaid work
$30,940 in 2024
Medicaid paid $30,940 for 1,190 billed services this clinician did in 2024, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 90 | $10,345 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 338 | $6,596 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 223 | $6,376 |
| Return visit (30+ min) | 75 | $2,474 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 147 | $2,236 |
| DETERMINATION REFRACTIVE STATE | 236 | $1,263 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 29 | $742 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 13 | $494 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 12 | $202 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 15 | $174 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 12 | $39 |
| 2024 | 1,190 | 11 | 49 | $30,940 |
| 2023 | 1,427 | 7 | 51 | $32,092 |
| 2022 | 976 | 6 | 38 | $27,128 |
| 2021 | 1,151 | 7 | 45 | $32,158 |
| 2020 | 392 | 4 | 24 | $7,808 |
| 2019 | 512 | 4 | 30 | $10,184 |
| 2018 | 534 | 5 | 28 | $11,279 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 343 | $10,445 |
| New patient visit (45+ min) | 138 | $8,240 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 414 | $7,718 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 176 | $1,855 |
| DETERMINATION REFRACTIVE STATE | 284 | $1,630 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 54 | $1,526 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 18 | $677 |
2022
| New patient visit (45+ min) | 102 | $8,574 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 247 | $8,088 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 259 | $5,086 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 97 | $3,034 |
| DETERMINATION REFRACTIVE STATE | 177 | $1,279 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 94 | $1,068 |
2021
| New patient visit (45+ min) | 120 | $9,709 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 256 | $7,845 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 321 | $7,167 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 76 | $3,328 |
| DETERMINATION REFRACTIVE STATE | 256 | $1,879 |
| New patient visit (30+ min) | 14 | $1,330 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 108 | $899 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 169 | $4,861 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 134 | $2,412 |
| DETERMINATION REFRACTIVE STATE | 74 | $474 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 15 | $60 |
2019
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 233 | $5,619 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 197 | $3,753 |
| DETERMINATION REFRACTIVE STATE | 70 | $702 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 12 | $111 |
2018
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 229 | $6,666 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 144 | $2,852 |
| DETERMINATION REFRACTIVE STATE | 108 | $1,071 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 40 | $422 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 13 | $268 |
Drugs they prescribed that Part D paid
$336,913
Pharmacies billed $336,913 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,891) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,421 generic and 1,470 brand-name prescriptions · $336,913 in drug cost · 40 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xiidra | 78 | $74,548 | $956 |
| Lumigan | 113 | $58,699 | $519 |
| Rocklatan | 43 | $22,168 | $516 |
| Restasis | 13 | $19,893 | $1,530 |
| Latanoprost | 1,115 | $17,875 | $16 |
See all 24 drugs
| Xiidra | 78 | $74,548 | $956 |
| Lumigan | 113 | $58,699 | $519 |
| Rocklatan | 43 | $22,168 | $516 |
| Restasis | 13 | $19,893 | $1,530 |
| Latanoprost | 1,115 | $17,875 | $16 |
| Rhopressa | 30 | $15,743 | $525 |
| Tyrvaya | 14 | $14,338 | $1,024 |
| Prednisolone Acetate | 248 | $11,813 | $48 |
| Brimonidine Tartrate-Timolol | 37 | $11,303 | $305 |
| Travoprost | 32 | $8,272 | $258 |
| Cyclosporine | 13 | $7,196 | $554 |
| Moxifloxacin | 276 | $6,957 | $25 |
| Brinzolamide | 24 | $6,357 | $265 |
| Brimonidine | 47 | $5,136 | $109 |
| Simbrinza | 12 | $4,576 | $381 |
| Azelastine | 109 | $3,103 | $28 |
| Dorzolamide-Timolol | 170 | $2,858 | $17 |
| Timolol Maleate | 103 | $1,426 | $14 |
| Neomycin-Polymyxin-Dexameth | 96 | $1,195 | $12 |
| Tobramycin-Dexamethasone | 11 | $924 | $84 |
| Erythromycin | 88 | $737 | $8 |
| Doxycycline Hyclate | 35 | $654 | $19 |
| Valacyclovir | 12 | $397 | $33 |
| Dorzolamide | 25 | $231 | $9 |
Year by year
| 2024 | 2,891 | 753 | 0% (0) | 51% | $336,913 |
| 2023 | 2,603 | 705 | 0% (0) | 53% | $331,787 |
| 2022 | 2,497 | 643 | 0% (0) | 54% | $300,839 |
| 2021 | 2,733 | 666 | 0% (0) | 59% | $299,193 |
| 2020 | 2,479 | 564 | 0% (0) | 54% | $282,013 |
| 2019 | 2,751 | 600 | 0% (0) | 51% | $358,238 |
| 2018 | 3,120 | 641 | 0% (0) | 54% | $377,051 |
| 2017 | 3,315 | 699 | 0% (0) | 56% | $421,884 |
| 2016 | 3,486 | 696 | 0% (0) | 65% | $441,785 |
| 2015 | 3,384 | 653 | 0% (0) | 67% | $411,720 |
| 2014 | 3,283 | 635 | None | 66% | $342,450 |
| 2013 | 3,555 | 661 | None | 72% | $352,377 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Xiidra | 59 | $61,113 | $1,036 |
| Lumigan | 102 | $57,934 | $568 |
| Latanoprost | 985 | $31,460 | $32 |
| Rocklatan | 43 | $22,350 | $520 |
| Restasis | 12 | $19,193 | $1,599 |
| Rhopressa | 31 | $15,450 | $498 |
| Prednisolone Acetate | 226 | $13,305 | $59 |
| Travoprost | 39 | $10,420 | $267 |
| Combigan | 18 | $9,356 | $520 |
| Cyclosporine | 17 | $8,828 | $519 |
| Brimonidine Tartrate-Timolol | 24 | $8,550 | $356 |
| Brinzolamide | 18 | $8,336 | $463 |
| Moxifloxacin | 245 | $8,132 | $33 |
| Travatan Z | 12 | $6,310 | $526 |
| Brimonidine | 37 | $6,223 | $168 |
| Dorzolamide-Timolol | 143 | $3,624 | $25 |
| Azelastine | 81 | $2,762 | $34 |
| Timolol Maleate | 82 | $2,011 | $25 |
| Neomycin-Polymyxin-Dexameth | 115 | $1,708 | $15 |
| Olopatadine | 42 | $1,551 | $37 |
| Doxycycline Hyclate | 25 | $1,231 | $49 |
| Valacyclovir | 27 | $1,197 | $44 |
| Tobramycin-Dexamethasone | 13 | $1,160 | $89 |
| Dorzolamide | 18 | $773 | $43 |
| Erythromycin | 53 | $487 | $9 |
| Doxycycline Monohydrate | 14 | $370 | $26 |
| Fluocinolone Acetonide | 11 | $294 | $27 |
2022: 26 drugs
| Lumigan | 97 | $54,665 | $564 |
| Latanoprost | 979 | $38,386 | $39 |
| Xiidra | 56 | $38,377 | $685 |
| Rocklatan | 55 | $24,181 | $440 |
| Restasis | 20 | $22,040 | $1,102 |
| Prednisolone Acetate | 234 | $12,589 | $54 |
| Combigan | 20 | $12,199 | $610 |
| Rhopressa | 26 | $9,530 | $367 |
| Travoprost | 26 | $7,560 | $291 |
| Moxifloxacin | 212 | $7,023 | $33 |
| Brimonidine Tartrate-Timolol | 15 | $6,291 | $419 |
| Brinzolamide | 15 | $5,911 | $394 |
| Simbrinza | 11 | $4,841 | $440 |
| Brimonidine | 37 | $4,485 | $121 |
| Travatan Z | 11 | $4,443 | $404 |
| Zerviate | 17 | $4,141 | $244 |
| Dorzolamide-Timolol | 115 | $3,543 | $31 |
| Azelastine | 83 | $3,170 | $38 |
| Valacyclovir | 27 | $2,408 | $89 |
| Olopatadine | 53 | $1,999 | $38 |
| Timolol Maleate | 76 | $1,803 | $24 |
| Ketorolac Tromethamine | 35 | $1,315 | $38 |
| Neomycin-Polymyxin-Dexameth | 74 | $1,164 | $16 |
| Doxycycline Monohydrate | 23 | $743 | $32 |
| Erythromycin | 40 | $446 | $11 |
| Fluocinolone Acetonide | 12 | $273 | $23 |
2021: 28 drugs
| Lumigan | 109 | $56,751 | $521 |
| Latanoprost | 928 | $36,678 | $40 |
| Xiidra | 41 | $26,307 | $642 |
| Combigan | 45 | $25,461 | $566 |
| Restasis | 17 | $22,448 | $1,320 |
| Zerviate | 53 | $14,834 | $280 |
| Prednisolone Acetate | 299 | $10,864 | $36 |
| Olopatadine | 168 | $8,795 | $52 |
| Moxifloxacin | 242 | $8,221 | $34 |
| Rhopressa | 20 | $8,176 | $409 |
| Rocklatan | 21 | $7,634 | $364 |
| Travoprost | 31 | $5,766 | $186 |
| Brimonidine | 29 | $5,700 | $197 |
| Simbrinza | 20 | $4,726 | $236 |
| Tobradex | 19 | $4,583 | $241 |
| Travatan Z | 13 | $4,360 | $335 |
| Dorzolamide-Timolol | 93 | $4,239 | $46 |
| Ketorolac Tromethamine | 126 | $2,356 | $19 |
| Azelastine | 61 | $2,168 | $36 |
| Tobramycin-Dexamethasone | 20 | $1,707 | $85 |
| Timolol Maleate | 70 | $1,543 | $22 |
| Neomycin-Polymyxin-Dexameth | 83 | $1,252 | $15 |
| Betaxolol | 15 | $707 | $47 |
| Valacyclovir | 21 | $589 | $28 |
| Fluocinolone Acetonide | 11 | $521 | $47 |
| Doxycycline Monohydrate | 14 | $437 | $31 |
| Erythromycin | 32 | $377 | $12 |
| Acyclovir | 19 | $126 | $7 |
2020: 29 drugs
| Lumigan | 116 | $59,492 | $513 |
| Latanoprost | 915 | $31,254 | $34 |
| Restasis | 20 | $26,587 | $1,329 |
| Combigan | 55 | $24,881 | $452 |
| Pazeo | 65 | $15,910 | $245 |
| Bepreve | 17 | $10,174 | $598 |
| Travatan Z | 32 | $9,909 | $310 |
| Xiidra | 17 | $9,600 | $565 |
| Olopatadine | 173 | $8,943 | $52 |
| Brimonidine | 27 | $7,021 | $260 |
| Moxifloxacin | 176 | $6,972 | $40 |
| Travoprost | 32 | $6,668 | $208 |
| Prednisolone Acetate | 184 | $6,520 | $35 |
| Azopt | 13 | $6,489 | $499 |
| Simbrinza | 22 | $5,104 | $232 |
| Dorzolamide-Timolol | 94 | $4,695 | $50 |
| Ilevro | 12 | $3,678 | $306 |
| Tobradex | 12 | $3,328 | $277 |
| Ketorolac Tromethamine | 106 | $2,285 | $22 |
| Tobramycin-Dexamethasone | 15 | $1,524 | $102 |
| Azelastine | 38 | $1,513 | $40 |
| Doxycycline Hyclate | 26 | $1,168 | $45 |
| Timolol Maleate | 56 | $1,156 | $21 |
| Epinastine | 17 | $1,073 | $63 |
| Dorzolamide | 11 | $1,024 | $93 |
| Neomycin-Polymyxin-Dexameth | 65 | $970 | $15 |
| Erythromycin | 45 | $577 | $13 |
| Valacyclovir | 14 | $480 | $34 |
| Fluocinolone Acetonide | 12 | $437 | $36 |
2019: 29 drugs
| Lumigan | 156 | $65,289 | $419 |
| Combigan | 73 | $33,023 | $452 |
| Restasis | 21 | $31,465 | $1,498 |
| Latanoprost | 920 | $30,216 | $33 |
| Pazeo | 101 | $23,239 | $230 |
| Travatan Z | 68 | $22,111 | $325 |
| Ilevro | 77 | $21,712 | $282 |
| Olopatadine | 174 | $14,763 | $85 |
| Moxifloxacin | 271 | $12,688 | $47 |
| Azopt | 23 | $9,751 | $424 |
| Durezol | 51 | $9,741 | $191 |
| Nevanac | 35 | $9,548 | $273 |
| Xiidra | 15 | $8,886 | $592 |
| Prednisolone Acetate | 160 | $6,771 | $42 |
| Brimonidine | 25 | $6,664 | $267 |
| Bepreve | 11 | $5,409 | $492 |
| Simbrinza | 16 | $4,350 | $272 |
| Dorzolamide-Timolol | 76 | $3,770 | $50 |
| Timolol Maleate | 75 | $2,218 | $30 |
| Tobramycin-Dexamethasone | 17 | $2,085 | $123 |
| Ketorolac Tromethamine | 78 | $1,997 | $26 |
| Azelastine | 36 | $1,864 | $52 |
| Dorzolamide | 22 | $1,505 | $68 |
| Epinastine | 13 | $1,068 | $82 |
| Valacyclovir | 12 | $898 | $75 |
| Neomycin-Polymyxin-Dexameth | 62 | $876 | $14 |
| Fluorometholone | 11 | $747 | $68 |
| Doxycycline Hyclate | 13 | $668 | $51 |
| Erythromycin | 34 | $385 | $11 |
2018: 31 drugs
| Lumigan | 185 | $73,080 | $395 |
| Combigan | 77 | $34,589 | $449 |
| Latanoprost | 1,020 | $26,331 | $26 |
| Travatan Z | 76 | $24,654 | $324 |
| Ilevro | 85 | $22,023 | $259 |
| Azopt | 57 | $21,991 | $386 |
| Restasis | 22 | $18,431 | $838 |
| Pazeo | 73 | $17,303 | $237 |
| Olopatadine | 198 | $17,219 | $87 |
| Nevanac | 60 | $15,605 | $260 |
| Durezol | 84 | $14,933 | $178 |
| Moxifloxacin | 258 | $12,873 | $50 |
| Xiidra | 20 | $10,514 | $526 |
| Brimonidine | 26 | $6,918 | $266 |
| Alphagan P | 15 | $6,256 | $417 |
| Prednisolone Acetate | 167 | $5,348 | $32 |
| Bepreve | 12 | $5,298 | $441 |
| Simbrinza | 13 | $3,994 | $307 |
| Dorzolamide-Timolol | 91 | $2,791 | $31 |
| Azelastine | 56 | $2,617 | $47 |
| Timolol Maleate | 123 | $2,505 | $20 |
| Tobramycin-Dexamethasone | 19 | $2,085 | $110 |
| Ketorolac Tromethamine | 62 | $1,262 | $20 |
| Epinastine | 23 | $1,073 | $47 |
| Valacyclovir | 16 | $1,027 | $64 |
| Neomycin-Polymyxin-Dexameth | 87 | $995 | $11 |
| Dorzolamide | 26 | $740 | $28 |
| Doxycycline Hyclate | 17 | $728 | $43 |
| Erythromycin | 33 | $232 | $7 |
| Ofloxacin | 11 | $141 | $13 |
| Polymyxin B Sul-Trimethoprim | 14 | $87 | $6 |
2017: 35 drugs
| Lumigan | 227 | $80,312 | $354 |
| Pataday | 136 | $36,247 | $267 |
| Combigan | 81 | $31,832 | $393 |
| Restasis | 52 | $29,551 | $568 |
| Travatan Z | 101 | $28,918 | $286 |
| Latanoprost | 1,052 | $25,721 | $24 |
| Olopatadine | 150 | $17,759 | $118 |
| Ilevro | 69 | $17,061 | $247 |
| Pazeo | 76 | $14,998 | $197 |
| Nevanac | 59 | $14,942 | $253 |
| Vigamox | 80 | $12,561 | $157 |
| Alphagan P | 37 | $12,426 | $336 |
| Durezol | 63 | $10,294 | $163 |
| Alrex | 16 | $9,903 | $619 |
| Brimonidine | 32 | $7,549 | $236 |
| Xiidra | 11 | $6,621 | $602 |
| Azopt | 13 | $5,984 | $460 |
| Prednisolone Acetate | 173 | $5,861 | $34 |
| Dorzolamide-Timolol | 139 | $4,863 | $35 |
| Simbrinza | 22 | $4,638 | $211 |
| Lotemax | 12 | $4,343 | $362 |
| Moxifloxacin | 47 | $4,035 | $86 |
| Azelastine | 69 | $3,287 | $48 |
| Xalatan | 13 | $3,039 | $234 |
| Epinastine | 38 | $2,451 | $65 |
| Acetazolamide | 11 | $1,865 | $170 |
| Valacyclovir | 24 | $1,840 | $77 |
| Doxycycline Hyclate | 14 | $1,545 | $110 |
| Timolol Maleate | 98 | $1,495 | $15 |
| Dorzolamide | 29 | $1,287 | $44 |
| Neomycin-Polymyxin-Dexameth | 84 | $1,074 | $13 |
| Polymyxin B Sul-Trimethoprim | 108 | $792 | $7 |
| Erythromycin | 55 | $518 | $9 |
| Fluocinolone Acetonide | 14 | $454 | $32 |
| Ketorolac Tromethamine | 19 | $434 | $23 |
2016: 31 drugs
| Pataday | 319 | $77,077 | $242 |
| Lumigan | 234 | $66,494 | $284 |
| Vigamox | 242 | $37,546 | $155 |
| Ilevro | 122 | $28,259 | $232 |
| Travatan Z | 82 | $27,617 | $337 |
| Restasis | 53 | $25,494 | $481 |
| Combigan | 88 | $25,491 | $290 |
| Latanoprost | 1,092 | $22,975 | $21 |
| Nevanac | 66 | $16,206 | $246 |
| Olopatadine | 92 | $15,026 | $163 |
| Prednisolone Acetate | 229 | $9,137 | $40 |
| Pazeo | 50 | $8,916 | $178 |
| Brimonidine | 37 | $8,351 | $226 |
| Alphagan P | 23 | $6,245 | $272 |
| Epinastine | 61 | $5,915 | $97 |
| Azopt | 14 | $5,795 | $414 |
| Durezol | 34 | $5,360 | $158 |
| Dorzolamide-Timolol | 141 | $4,491 | $32 |
| Simbrinza | 26 | $4,226 | $163 |
| Lotemax | 16 | $4,204 | $263 |
| Azelastine | 68 | $3,911 | $58 |
| Travoprost | 16 | $2,392 | $149 |
| Tobramycin-Dexamethasone | 16 | $1,639 | $102 |
| Valacyclovir | 14 | $1,587 | $113 |
| Doxycycline Hyclate | 18 | $1,221 | $68 |
| Timolol Maleate | 67 | $1,219 | $18 |
| Erythromycin | 61 | $890 | $15 |
| Dorzolamide | 15 | $815 | $54 |
| Acetazolamide | 11 | $812 | $74 |
| Neomycin-Polymyxin-Dexameth | 26 | $426 | $16 |
| Polymyxin B Sul-Trimethoprim | 48 | $411 | $9 |
2015: 29 drugs
| Pataday | 401 | $85,610 | $213 |
| Lumigan | 237 | $54,654 | $231 |
| Patanol | 89 | $33,047 | $371 |
| Travatan Z | 111 | $27,979 | $252 |
| Vigamox | 194 | $27,385 | $141 |
| Restasis | 54 | $24,477 | $453 |
| Latanoprost | 1,118 | $22,094 | $20 |
| Combigan | 89 | $21,073 | $237 |
| Nevanac | 75 | $16,984 | $226 |
| Ilevro | 58 | $13,473 | $232 |
| Alrex | 19 | $11,424 | $601 |
| Epinastine | 90 | $9,903 | $110 |
| Prednisolone Acetate | 202 | $8,338 | $41 |
| Azopt | 21 | $5,926 | $282 |
| Brimonidine | 32 | $5,070 | $158 |
| Azelastine | 64 | $4,636 | $72 |
| Lotemax | 12 | $3,864 | $322 |
| Dorzolamide-Timolol | 109 | $3,681 | $34 |
| Alphagan P | 21 | $3,365 | $160 |
| Travoprost | 19 | $2,280 | $120 |
| Valacyclovir | 18 | $1,988 | $110 |
| Besivance | 14 | $1,933 | $138 |
| Simbrinza | 13 | $1,762 | $136 |
| Acetazolamide | 15 | $1,734 | $116 |
| Tobramycin-Dexamethasone | 16 | $1,641 | $103 |
| Erythromycin | 72 | $1,128 | $16 |
| Timolol Maleate | 59 | $819 | $14 |
| Dorzolamide | 14 | $420 | $30 |
| Neomycin-Polymyxin-Dexameth | 16 | $185 | $12 |
2014: 29 drugs
| Pataday | 358 | $66,455 | $186 |
| Lumigan | 225 | $40,798 | $181 |
| Restasis | 61 | $23,250 | $381 |
| Latanoprost | 1,049 | $21,638 | $21 |
| Travatan Z | 111 | $21,471 | $193 |
| Patanol | 81 | $19,002 | $235 |
| Vigamox | 166 | $18,585 | $112 |
| Nevanac | 102 | $17,206 | $169 |
| Epinastine | 141 | $16,309 | $116 |
| Combigan | 83 | $14,567 | $176 |
| Alrex | 22 | $9,179 | $417 |
| Brimonidine | 38 | $7,459 | $196 |
| Alphagan P | 29 | $6,767 | $233 |
| Prednisolone Acetate | 178 | $5,862 | $33 |
| Dorzolamide-Timolol | 111 | $5,838 | $53 |
| Bepreve | 23 | $5,014 | $218 |
| Lotemax | 21 | $4,912 | $234 |
| Azelastine | 52 | $4,549 | $87 |
| Tobradex | 23 | $4,114 | $179 |
| Tobramycin-Dexamethasone | 40 | $3,926 | $98 |
| Travoprost | 25 | $3,678 | $147 |
| Ilevro | 17 | $3,124 | $184 |
| Azopt | 11 | $2,518 | $229 |
| Lastacaft | 11 | $1,474 | $134 |
| Acetazolamide | 13 | $1,181 | $91 |
| Erythromycin | 71 | $1,014 | $14 |
| Timolol Maleate | 53 | $603 | $11 |
| Bacitracin-Polymyxin | 17 | $309 | $18 |
| Neomycin-Polymyxin-Dexameth | 17 | $155 | $9 |
2013: 27 drugs
| Pataday | 457 | $67,391 | $147 |
| Lumigan | 214 | $33,782 | $158 |
| Nevanac | 201 | $29,954 | $149 |
| Vigamox | 244 | $24,973 | $102 |
| Travatan Z | 130 | $24,665 | $190 |
| Patanol | 136 | $22,621 | $166 |
| Restasis | 58 | $22,116 | $381 |
| Latanoprost | 911 | $21,245 | $23 |
| Epinastine | 185 | $17,901 | $97 |
| Combigan | 68 | $10,066 | $148 |
| Alphagan P | 55 | $9,597 | $174 |
| Tobradex | 52 | $9,081 | $175 |
| Azelastine | 65 | $6,026 | $93 |
| Alrex | 15 | $5,776 | $385 |
| Lotemax | 28 | $5,774 | $206 |
| Brimonidine | 21 | $5,074 | $242 |
| Azopt | 29 | $4,991 | $172 |
| Bepreve | 26 | $4,597 | $177 |
| Dorzolamide-Timolol | 95 | $4,082 | $43 |
| Tobramycin-Dexamethasone | 38 | $3,716 | $98 |
| Prednisolone Acetate | 224 | $3,498 | $16 |
| Astepro | 11 | $1,325 | $120 |
| Bacitracin | 21 | $1,232 | $59 |
| Erythromycin | 73 | $1,177 | $16 |
| Dorzolamide | 13 | $686 | $53 |
| Timolol Maleate | 46 | $591 | $13 |
| Neomycin-Polymyxin-Dexameth | 12 | $88 | $7 |
Money from drug and device companies
$673 in 2025
| 2025 | 11 | 33 | None | $673 |
| 2024 | 9 | 18 | None | $451 |
| 2023 | 8 | 20 | None | $432 |
| 2022 | 9 | 23 | None | $532 |
| 2021 | 5 | 11 | None | $285 |
| 2020 | 3 | 4 | None | $67 |
| 2019 | 8 | 27 | None | $433 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Xiidra | $145 | 8 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $135 | 12 payments
|
| Lumibird Medical | None | $110 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $61 | 3 payments
|
| Amgen | Tepezza | $53 | 2 payments
|
| Thea Pharma | Iyuzeh | $38 | 2 payments
|
See all 33 published payments
| Tarsus Pharmaceuticals | Meals · 2025-12-16 | Xdemvy | $2 |
| Tarsus Pharmaceuticals | Meals · 2025-12-16 | Xdemvy | $10 |
| Bausch & Lomb Americas | Meals · 2025-12-02 | Envista Envy Iol | $15 |
| Thea Pharma | Meals · 2025-10-21 | Iyuzeh | $19 |
| Oyster Point Pharma | Meals · 2025-10-15 | Tyrvaya | $21 |
| Bausch & Lomb Americas | Meals · 2025-10-05 | Vyzulta | $24 |
| Amgen | Meals · 2025-09-10 | Tepezza | $27 |
| Tarsus Pharmaceuticals | Meals · 2025-08-23 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-08-23 | Xdemvy | $11 |
| Oyster Point Pharma | Meals · 2025-08-19 | Tyrvaya | $25 |
| Tarsus Pharmaceuticals | Meals · 2025-08-08 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-08-08 | Xdemvy | $8 |
| Bausch & Lomb Americas | Meals · 2025-07-29 | Xiidra | $26 |
| Bausch & Lomb Americas | Meals · 2025-07-29 | Xiidra | $1 |
| Alcon Vision | Meals · 2025-07-22 | Tryptyr | $35 |
| Bausch & Lomb Americas | Meals · 2025-07-10 | Miebo | $18 |
| Tarsus Pharmaceuticals | Meals · 2025-06-18 | Xdemvy | $16 |
| Dompe US | Meals · 2025-06-11 | Oxervate | $20 |
| Bausch & Lomb Americas | Meals · 2025-05-14 | Miebo | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-05-02 | Xdemvy | $25 |
| Thea Pharma | Meals · 2025-04-22 | Iyuzeh | $20 |
| Abbvie | Meals · 2025-04-15 | Lumigan | $23 |
| Harrow Eye | Meals · 2025-04-08 | Vevye | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-03-14 | Xdemvy | $2 |
| Tarsus Pharmaceuticals | Meals · 2025-03-14 | Xdemvy | $14 |
| Tarsus Pharmaceuticals | Meals · 2025-03-14 | Xdemvy | $12 |
| Bausch & Lomb Americas | Meals · 2025-03-13 | Xiidra | $20 |
| Amgen | Meals · 2025-03-04 | Tepezza | $26 |
| Lumibird Medical | Meals · 2025-03-04 | None | $110 |
| Tarsus Pharmaceuticals | Meals · 2025-02-19 | Xdemvy | $22 |
| Oyster Point Pharma | Meals · 2025-02-04 | Tyrvaya | $15 |
| Astellas Pharma US | Meals · 2025-01-07 | Izervay | $32 |
| Bausch & Lomb Americas | Meals · 2025-01-06 | Xiidra | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $451
| Biotissue Holdings | None | $114 | 5 payments
|
| Oyster Point Pharma | Tyrvaya | $84 | 3 payments
|
| Harrow Eye | Vevye | $58 | 2 payments
|
| Amgen | Tepezza | $58 | 2 payments
|
| Alcon Vision | Rocklatan | $42 | 2 payments
|
| Abbvie | Lumigan | $26 | 1 payment
|
| Tarsus Pharmaceuticals | Xdemvy | $24 | 1 payment
|
| Thea Pharma | Iyuzeh | $24 | 1 payment
|
| Bausch & Lomb Americas | Envista Mx60 Iol | $21 | 1 payment
|
2023: $432
| Abbvie | Lumigan | $113 | 5 payments
|
| Alcon Vision | Rocklatan | $76 | 4 payments
|
| Bausch & Lomb Americas | Vyzulta | $73 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $63 | 3 payments
|
| Thea Pharma | Iyuzeh | $39 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $28 | 1 payment
|
| Sight Sciences | Tearcare System | $24 | 1 payment
|
| RxSight | Rxsight Contact Lens | $16 | 1 payment
|
2022: $532
| Alcon Vision | Rhopressa | $137 | 7 payments
|
| Mallinckrodt Hospital Products | Acthar | $122 | 3 payments
|
| Bausch & Lomb Americas | Vyzulta | $107 | 5 payments
|
| Novartis Pharmaceuticals | Xiidra | $47 | 2 payments
|
| Abbvie | Lumigan | $43 | 2 payments
|
| Merck Sharp & Dohme | Bridion | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $21 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $17 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $12 | 1 payment
|
2021: $285
| Mallinckrodt Hospital Products | Acthar | $136 | 4 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $86 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $22 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $22 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $19 | 1 payment
|
2020: $67
| Aerie Pharmaceuticals | Rhopressa | $31 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $19 | 1 payment
|
| Allergan | Restasis | $18 | 1 payment
|
2019: $433
| Allergan | Lumigan | $156 | 13 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $113 | 7 payments
|
| Sun Pharmaceutical Industries | Cequa | $45 | 2 payments
|
| Eyevance Pharmaceuticals | Flarex | $26 | 1 payment
|
| Dompe US | Oxervate | $25 | 1 payment
|
| Aerie Pharmaceuticals | Rocklatan | $24 | 1 payment
|
| Akorn | Zioptan | $23 | 1 payment
|
| Horizon Therapeutics plc | None | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1578506960
- Licence
- CA G751390
- Trained
- University of California, Davis School of Medicine, 1991 · 35 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1850 Sullivan Ave, Ste 500, Daly City, CA, 94015
- NPI first listed
- 2006-06-13
- NPI last updated
- 2008-02-08
This is when the NPI record was last certified, not a medical board exam.